Lantheus Holdings (LNTH) Gains from Investment Securities (2014 - 2026)
Lantheus Holdings (LNTH) reported Gains from Investment Securities of $207.0 for Q1 2026, down 100.0% year-over-year from $23.7 million in Q1 2025, and down 100.0% quarter-over-quarter from $12.6 million in Q4 2025.
Lantheus Holdings (LNTH) Gains from Investment Securities (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Gains from Investment Securities data on file, last reported at $207.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $207.0, down 100.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $207.0 (down 100.0% YoY), and the FY2025 annual result was $196516.0, down 83.85% from the prior year.
- Gains from Investment Securities slipped to $207.0 in Q1 2026 per LNTH's latest filing, from $12.6 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $29.8 million in Q4 2024 and troughed at -$11.2 million in Q4 2022.
- A 5-year average of $3.4 million and a median of $13000.0 in 2025 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2023 and 2025: Gains from Investment Securities sank 1223.96% in 2023, then jumped 7743.05% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at -$11.2 million in 2022, then surged by 141.14% to $4.6 million in 2023, then surged by 544.74% to $29.8 million in 2024, then tumbled by 57.63% to $12.6 million in 2025, then slumped by 100.0% to $207.0 in 2026.
- Business Quant data shows LNTH's Gains from Investment Securities at $207.0 in Q1 2026, $12.6 million in Q4 2025, and $13000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 207.00 |
| Mar 31, 2026 | 207.00 |
| Dec 31, 2025 | 12.62 Mn |
| Dec 31, 2025 | 12.62 Mn |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 23.69 Mn |
| Mar 31, 2025 | 23.69 Mn |
| Dec 31, 2024 | 29.79 Mn |
| Dec 31, 2024 | 29.79 Mn |
| Sep 30, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 302,000.00 |
| Mar 31, 2024 | 302,000.00 |
| Dec 31, 2023 | 4.62 Mn |
| Dec 31, 2023 | 4.62 Mn |